Gasporox AB (publ) (STO:GPX)
7.40
+0.60 (8.82%)
Feb 11, 2026, 12:36 PM CET
Gasporox AB Company Description
Gasporox AB (publ) engages in the development and commercialization of tunable diode laser absorption spectroscopy technology in Sweden.
The company offers Instruments, such as GPX1500 vial, GPX1500 film pharma, and GPX1500 film food; linearch machines; VialArch, BottleArch, AutoMAP pharma and food, and CellSpect sensors; and GPX HMI software.
It also provides laboratory services, including alpha studies, multi-parameter analysis, batch check, stability studies, and customer defined studies; and IQ/OQ protocols, remote calibration services, training, and customized accessories for the GPX1500.
The company was incorporated in 2005 and is based in Lund, Sweden.
Gasporox AB (publ)

| Country | Sweden |
| Founded | 2005 |
| Industry | Scientific & Technical Instruments |
| Sector | Technology |
| Employees | 20 |
| CEO | Marta Xu |
Contact Details
Address: Tellusgatan 13 Lund, 224 57 Sweden | |
| Website | gasporox.se |
Stock Details
| Ticker Symbol | GPX |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0008991624 |
| SIC Code | 3823 |
Key Executives
| Name | Position |
|---|---|
| Hanna Sjostrom | Chief Executive Officer of GPX Medical AB |
| Dr. Marta Lewander Xu Ph.D. | Chief Executive Officer |
| Fredrik Hansson | Chief Financial Officer |
| Roland Koch | Vice President and Director of Sales and Applications |